Inflammatory cytokines: Putative regulators of neuronal and neuro- endocrine function

Brain Research Reviews

Volumn 26, Issue 2-3, 1998, Pages 320-326

  Raber, J ^a   Sorg, O ^b   Horn, T F W ^c   Yu, N ^c   Koob, G F ^c   Campbell, I L ^c   Bloom, F E ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL TISSUE; CONFERENCE PAPER; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOREGULATION; NEUROENDOCRINE DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; MICE; NEURONS; NEUROSECRETORY SYSTEMS; NEUROTRANSMITTER AGENTS; RATS;

EID: 0032078509     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00041-6     Document Type: Conference Paper

References (30)

1. F.E. Bloom, Neurotransmission and the central nervous system. in: J.G. Hardman, L.E. Limbird (Eds.), Goodman and Gilman's The Pharmacological Basis of Medical Therapeutics, McGraw-Hill, New York, 1996, pp. 267-294.
2. Raber J., Bloom F.E. IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. J. Neurosci. 14:1994;6187-6195.
3. Raber J., Pich E.M., Koob G.F., Bloom F.E. IL-1β potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Neuroendocrinology. 59:1994;208-217.
4. Raber J., Koob G.F., Bloom F.E. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J. Pharmacol. Exp. Ther. 272:1995;815-824.
5. Pich E.M., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15:1995;5439-5447.
6. Raber J., Bloom F.E. Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation [published erratum appears in Neuroscience 1996 Jul;73(2):623]. Neuroscience. 71:1996;747-759.
7. Mucke L., Masliah E., Campbell I.L. Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr. Top. Microbiol. Immunol. 202:1995;187-205.
8. Raber J., Toggas S.M., Lee S., Bloom F.E., Epstein C.J., Mucke L. Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology. 226:1996;362-373.
9. Prospero-Garcia O., Gold L.H., Fox H.S., Polis I., Koob G.F., Bloom F.E., Henriksen S.J. Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc. Natl. Acad. Sci. USA. 93:1996;14158-14163.
10. Phillips T.R.et al. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J. Neurovirol. 2:1996;388-396.
11. J. Raber, R.D. O'Shea, F.E. Bloom, I.L. Campbell, Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the central nervous system of mice, J. Neurosci. (1997) in press.
12. Campbell I.L., Chiang C.S. Cytokine involvement in central nervous system disease. Implications from transgenic mice. Ann. NY Acad. Sci. 771:1995;301-312.
13. Campbell I.L. Neuropathogenic actions of cytokines assessed in transgenic mice. Int. J. Dev. Neurosci. 13:1995;275-284.
14. Sorg, O., Horn, T.F.W., Yu, N., Gruol, D.L., Bloom, F.E., Inhibition of astrocyte glutamate uptake by reactive oxygen species: Role of antioxidant enzymes, Molec. Med. 3 (1997) in press.
15. 1 regulate corticotropin releasing factor release from the amygdala: comparison with the hypothalamic response. Neurochem. Int. 30:1997;455-463.
16. Campbell I.L., Abraham C., Masliah E., Kemper P., Inglis J., Oldstone M., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA. 90:1993;10061-11065.
17. Schöbitz B., de Kloet E.R., Sutanto W., Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA. Eur. J. Neurosci. 5:1993;1426-1435.
18. De Kloet E.R., Oitzl M.S., Schobitz B. Cytokines and the brain corticosteroid receptor balance: relevance to pathophysiology of neuroendocrine-immune communication. Psychoneuroendocrinology. 19:1994;121-134.
19. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. USA. 94:1997;1500-1505.
20. Gold L.H.et al. Behavioral and neurophysiological effects of CNS expression of cytokines in transgenic mice. Adv. Exp. Med. Biol. 402:1996;199-205.
21. B. Halliwell, J. Gutteridge (Eds.), Free Radicals in Biology and Medicine, Oxford, Oxford University Press, 1989.
22. Przedborski S., Donaldson D., Jakowec M., Kish S.J., Guttman M., Rosoklija G., Hays A.P. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;158-165.
23. Rothwell N.J., Strijbos P.J. Cytokines in neurodegeneration and repair. Int J Dev. Neurosci. 13:1995;179-185.
24. Nichol K.A., Schulz M.W., Bennett M.R. Nitric oxide-mediated death of cultured neonatal retinal ganglion cells: neuroprotective properties of glutamate and chondroitin sulfate proteoglycan. Brain Res. 697:1995;1-16.
25. Lipton S.A. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol. Neurobiol. 8:1994;181-196.
26. Ye Z.C., Sontheimer H. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport. 7:1996;2181-2185.
27. Phillips T.R., Prospero-Garcia O., Puaoi D.L., Lerner D.L., Fox H.S., Olmsted R.A., Bloom F.E., Henriksen S.J., Elder J.H. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 75:1994;979-987.
28. Henriksen S.J., Prospero-Garcia O., Phillips T.R., Fox H.S., Bloom F.E., Elder J.H. Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. Curr. Top. Microbiol. Immunol. 202:1995;167-186.
29. Lane T.E., Buchmeier M.J., Watry D., Jakubowski D.B., Fox H.S. Serial passage of microglial SIV results in selection of homogeneous env quasispecies in the brain. Virology. 212:1995;458-465.
30. Steffensen S.C., Campbell I.L., Henriksen S.J. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 652:1994;149-153.